Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion (068270 KP)
Watchlist
22
Analysis
Health Care
•
South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Samsung Biologics
•
05 Oct 2016 12:01
Samsung BioLogics IPO Part 3 - Valuation
Samsung BioLogics has just filed an IPO report. I will summarize Samsung BioLogics IPO report in the following three parts:Part 1 - IPO...
Sanghyun Park
Follow
335 Views
Share
bearish
•
Samsung Biologics
•
04 Oct 2016 07:43
Samsung BioLogics IPO Price, Capital Investment Plan & Valuation Issue
In a regulatory filing (last Friday), Samsung Biologics announced its plan to raise ₩1.23tril (US$1.12bil) of new shares. Samsung BioLogics plans...
Sanghyun Park
Follow
279 Views
Share
bullish
•
Thematic (Sector/Industry)
•
04 Oct 2016 03:57
Korea Stock Market Monthly Recap #6 - (September 2016)
The six major events in the Korea Stock Market in September were as follows: LG Chem-LG Life Sciences merger, Hanjin Shipping applying for court...
Douglas Kim
Follow
167 Views
Share
bullish
•
Thematic (Sector/Industry)
•
17 Sep 2016 22:47
Korea's Foreign Direct Investment Trend
LS Cable & System Asia Ltd (229640 KS) and Hwaseung Enterprise Co. are two Vietnam related stocks that will be listed on the Korea Stock Market...
Douglas Kim
Follow
183 Views
Share
bearish
•
Celltrion Inc
•
16 Sep 2016 06:18
More Harsh Reality from Teva
U.S. healthcare industry leaders from across the spectrum of industry segments continue to downplay the near-term adoption of biosimilars in the...
Kemp Dolliver, CFA
198 Views
Share
First
Previous
94
95
96
97
98
99
100
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x